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Synthesis of new C-5-triazolyl-functionalized
thymidine analogs and their ability to engage in
aromatic stacking in DNA : DNA and DNA : RNA
duplexes†
Mick Hornum, Alevtina Djukina, Ann-Katrin Sassnau and Poul Nielsen*
1-Phenyl-1,2,3-triazole scaﬀolds on the 5-position of pyrimidine nucleosides have previously shown to
enhance nuclease stability and increase the duplex thermal stability (Tm) by engaging in duplex stacking inter-
actions. In this study, we have introduced two new derivatives of this scaﬀold in DNA : DNA and DNA : RNA
duplexes in order to explore the thermal eﬀects of (1) using a 1,5-triazole instead of the usual 1,4-triazole,
and (2) replacing the apolar phenyl substituent with a polar uracil-5-yl substituent.
Introduction
The 5-position of pyrimidines has long been a popular site for
fine-tuning the physical and biological properties of oligo-
nucleotides and nucleic acid duplexes.1 In addition to their
well-defined location in the major groove of duplexes, 5-substi-
tuents are known to influence the stacking of nucleobases in
duplexes. For instance, a 5-methyl group increases the mole-
cular polarizability of the pyrimidine, thereby increasing the
base stacking,2 which is widely used in e.g. antisense thera-
peutics for increasing the aﬃnity of oligonucleotides toward
complementary RNA.3 The stacking interactions can be further
augmented by employing small 5-alkynyl or 5-heteroaryl sub-
stituents, such as 5-propyn-1-yl4 and 5-thiazol-2-yl.5
Elaboration of these structures has enabled us to design
5-triazole-substituted pyrimidine nucleosides, which were
shown to provide dramatic improvements in duplex stability.6
In addition, oligodeoxynucleotides bearing these monomers
maintain high base-pairing specificity,6,7 show improved stabi-
lity toward 3′-exonucleoases7b and compatibility with RNase H
enzymes,8 making these 5-triazole-substituted pyrimidine
building blocks strong candidates in antisense therapeutics.
Starting from 5-ethynyl pyrimidine nucleosides,9 the copper(I)-
catalyzed alkyne–azide cycloaddition10 (CuAAC) has allowed us
to employ an arsenal of diﬀerent aliphatic or aromatic azides
to yield an analogous set of 5-(1-substituted-1,2,3-triazole)-
functionalized nucleoside products with relative ease.6,7,11 The
studies showed that monomer X (Fig. 1) with a 1-phenyltriazol-
4-yl moiety6,7a stacks more strongly than the triazole alone,
and diﬀerent small substituents on the phenyl group can
enhance stacking interactions slightly.7a,11 While single in-
corporations of these monomers generally destabilize
DNA : DNA and DNA : RNA duplexes, due to their displacement
of the otherwise well-ordered water molecules within the
major groove of the duplex, multiple incorporations evoke
thermostabilizing eﬀects that more than compensates for the
solvation penalty, suggesting that the phenyltriazoles stack
eﬃciently in the major groove.
Although aromatic stacking provides the dominating contri-
bution to the overall stability of the nucleic acid duplexes in
general,12 the nature of this interaction is not well understood.
It is now well-established that π–π stacking is not precisely
described by the mere interaction of π clouds above and below
the planes of neighbouring aromatic rings.13 Both enthalpy-
driven electrostatic interactions and van der Waals dispersion
forces, as well as entropy-driven solvophobic eﬀects have been
suggested as the major components behind the stacking in
aqueous media,14 but no clear unified picture regarding the rela-
tive importance of these basic physical contributions exists.12
Fig. 1 Structures of monomers X, Y and Z.
†Electronic supplementary information (ESI) available: Selected NMR spectra
and MALDI-TOF of oligonucleotides. See DOI: 10.1039/c6ob00609d
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While it is accepted that stacking correlates with the surface
area, there is no satisfactory answer to the correlation between
other physical properties such as hydrophobicity or geometry.
In the present study, we have introduced more radical
changes to our 1-phenyl-1,2,3-triazole scaﬀold in order to inves-
tigate the scope of these stacking interactions in the aqueous
media of the major groove. To this end, we hereby report our
findings with monomers Y and Z (Fig. 1), where we have
explored the thermostabilizing and structural consequences of,
respectively, increasing the hydrophilicity of the 5-triazole sub-
stituent significantly, and altering the substitution geometry of
the triazole ring (1,4- vs. 1,5-disubstituted triazole).
Monomer Y features a uracil–triazole moiety on the 5-posi-
tion and is hereby designed to be a simple hydrophilic version
of the traditional phenyl–triazole moiety of monomer X. Being
roughly the same size as the phenyl substituent, the uracil sub-
stituent also possesses very large bond moments and is less
polarizable, and so these two monomers are expected to stack
energetically diﬀerently in the major groove. The other new
monomer, Z, is designed to be a geometric analog of
monomer X, where the phenyl substituent is projected non-
linearly into the major groove as opposed to monomer X. This
bent structure is interesting in terms of understanding what
geometry of the 5-substituent is most suitable for engaging in
stacking interactions in the major groove. While these two
structures diﬀer only in their substitution pattern of the 1,2,3-
triazole ring, we speculated that their slightly diﬀerent vectors
of expanding into the major groove could exert diametrically
opposed eﬀects on the duplex structure.
Results
Chemical synthesis
The new monomers Y and Z were successfully incorporated
into oligodeoxynucleotides on an automated solid-phase DNA
synthesizer using the nucleoside phosphoramidites 3 and 8
(Scheme 1) when activated by 1H-tetrazole. The oligo-
nucleotide sequences chosen for the present study is a T-rich
9-mer sequence (5′-dGTGTTTTGC) with one to four central
incorporations of Y and Z in accordance with some of our pre-
vious studies with X.6,7a,11
The core structure of monomer Y was successfully obtained
by treating the well-known 5-ethynyl-5′-O-DMT-2′-deoxy-
uridine15 (1) with freshly synthesized 5-azidouracil16 under
copper(I) catalysis, similar to our protocol for synthesis of X.17
This aﬀorded nucleoside 2 in 75% yield. The structure of 2 was
carefully identified by means of 2D HSQC, COSY and HMBC in
order to confirm the precise structure of the 5-substituent.
Subsequent phosphitylation of nucleoside 2 under standard
conditions gave phosphoramidite 3. For the synthesis of
monomer Z, the 1,5-disubstituted triazole scaﬀold (nucleoside
5) was obtained by treating acetyl-protected 5-ethynyl-2′-deoxy-
uridine (4) with phenylazide under a cooperative eﬀect of
microwave activation and ruthenium catalysis18 analogous to a
procedure used by Agrofoglio and co-workers19 for the regio-
selective generation of similar 1,5-disubstituted 1,2,3-triazolo-
nucleosides. Small amounts of the formed 1,4-regioisomer was
removed by chromatography, and nucleoside 5 was isolated in
80% yield. Although this reaction type generally accepts un-
protected nucleosides,18b we observed that protecting groups
were necessary in order to minimize unspecific side reactions.
Phosphoramidite 8 was obtained in good yield after deacetyla-
tion (to form 6), selective 5′-O-tritylation (to form 7) and finally
3′-O-phosphitylation; all under standard conditions.
UV spectroscopy
The oligonucleotides were mixed in a phosphate buﬀered
saline solution with the complementary DNA and RNA
sequences using 1.5 μM of each strand. The melting tempera-
tures (Tm) of the resulting DNA : DNA and DNA : RNA duplexes
(Table 1) were determined by means of a UV spectrometer
using a Peltier Temperature Programmer. The Tm values were
derived from the first derivatives of the melting curves
recorded at 260 nm (as duplicate readings that agreed within
±0.5%).
As shown in Table 1, a single incorporation of Y in the
centre of DNA : DNA destabilizes the duplex by −1.7 °C (entry
6), which is, however, significantly less than that for X (ΔTm =
−5.0 °C, entry 2), suggesting that the polar profile of Y is much
Scheme 1 Reagents and conditions: (a) 5-azidouracil, Na ascorbate,
CuSO4, H2O, t-BuOH, rt, 75%; (b) P(N(i-Pr)2)O(CH2)2CN, diisopropyl-
ammonium tetrazolide, CH2Cl2, rt, 71% 3, 50% 8; (c) automated DNA
synthesis; (d) phenylazide, Cp*RuCl(PPh3)2, MTBE, THF, MW, 100 °C;
80%; (e) NH3, MeOH, rt, 67%; (f ) DMTCl, pyridine, 57%.
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better accommodated in the major groove than the non-polar
residue of X. As expected, the degree of destabilization is com-
pensated once several residues are installed: the DNA : DNA
duplexes featuring three and four consecutive Y residues are
thermally stabilized by +2.0 °C (entry 8) and +5.3 °C (entry 9),
respectively, which is significantly better than what is achieved
with 3× X (−3.0 °C, entry 3) and 4× X (−1.0 °C, entry 4). While
the stacking between two X residues (entry 2) appears slightly
better than between two Y residues (entry 7), the favorable
stacking of multiple Y residues seems more consistent and, in
general, better than multiple X residues (Fig. 2).
For a single incorporation of monomer Z in the DNA : DNA
duplex (entry 10), a relatively weak melting transition was
observed at 19.7 °C, which represents a remarkable destabiliza-
tion of −13.3 °C compared to the unmodified duplexes (entry
1) and −8.3 °C relative to that of its regioisomer X (entry 2).
Similarly, the duplex bearing two Z residues was destabilized
by −14.0 °C (or −7.0 °C per mod., entry 11), however, the
melting transition for this entry was extraordinarily weak. No
clear melting was observed for the entry with 3× Z (entry 12),
which is an indication of either the dim hyperchromicity
exerted by the presence of Z or the lack of any hybridization
such that no denaturation occurs. In the study involving target-
ing complementary RNA, all entries with Z showed no clear
melting transitions; even when measured down to 5 °C and at
an increased salt concentration. Monomer Z was found to
cause a slight redshift of the absorption maximum, but also
no clear melting was detected when recorded at λmax =
252 nm.
In the case of Y in the DNA : RNA study, an initial destabili-
zation of −1.1 °C was observed for the initial incorporation
(entry 6) compared to the native duplex, but with each
additional Y residue, the melting temperature increases
almost linearly with a gradient of roughly +7 °C per incorpor-
ation (entries 7–9). Therefore, it follows the exact same ten-
dency as X, and their thermostabilizing eﬀects on DNA : RNA
duplexes are indeed almost equivalent as evident from Fig. 3.
The high-aﬃnity targeting of complementary RNA for oligo-
nucleotides containing four incorporations of Y allowed us to
study its base-pairing specificity toward mismatched RNA
strands (Table 2). By introducing a Y : U mismatched base pair
in the centre of the duplex (entry 2), we found that the Tm
plummeted by −21.9 °C relative to the fully complementary
DNA : RNA duplex, indicating that the A → U mutation is very
well-discriminated similar to what was observed for the corres-
ponding X : U mismatch (entry 1, ΔTm = −20.5 °C). A central
Y : C mispair was also found to be very well-discriminated
(ΔTm = −18.0 °C), albeit not as exceptional as the corres-
ponding X : C mismatch (ΔTm = −27.5 °C). Traditionally, the
A → G transition is the least discriminated mutation (ΔTm =
−8.8 °C) as the Y : G mispair presumably adopts a wobble
configuration.
Table 1 Hybridization data for the synthesized oligonucleotides against
matched DNA and RNA strands
# Sequence
Tm
a (ΔTm/mod.) [°C]
Compl. DNA Compl. RNA
1 5′-dGTG TTT TGC 33.0 31.0
2 5′-dGTG TXT TGC 28.0b (−5.0) 29.0b (−2.0)
3 5′-dGTG TXX TGC 30.5c (−1.5) 37.5c (+3.3)
4 5′-dGTG XXX TGC 30.0c (−1.0) 43.0c (+4.0)
5 5′-dGTG XXX XGC 32.0b (−0.3) 51.5b (+5.1)
6 5′-dGTG TYT TGC 31.3 (−1.7) 29.9 (−1.1)
7 5′-dGTG TYY TGC 32.2 (−0.4) 36.2 (+2.6)
8 5′-dGTG YYY TGC 35.0 (+0.7) 43.1 (+4.0)
9 5′-dGTG YYY YGC 38.3 (+1.3) 52.0 (+5.2)
10 5′-dGTG TZT TGC 19.7 (−13.3) n.t.d
11 5′-dGTG TZZ TGC 19.0 (−7.0) n.t.d
12 5′-dGTG ZZZ TGC n.t.d n.t.d
aMelting temperatures (Tm) are derived from the maxima of the first
derivatives of the absorbance (260 nm) vs. temperature curves. The
samples contained 1.5 μM of each oligonucleotide and 1.5 μM of
complementary DNA or RNA (5′-GCAAAACAC) in PBS buﬀer (2.5 mM
Na2HPO4, 5.0 mM NaH2PO4, 100 mM NaCl, 0.1 mM EDTA, pH 7).
Values in brackets show changes in the Tm values per modification
compared to the unmodified duplex. b Value taken from ref. 6. c Value
taken from ref. 7a. dNo clear transition was observed.
Fig. 2 Graphical illustration of correlation between Tm and the number
of incorporations of X (red), Y (blue) and Z (green) in the DNA : DNA
duplexes.
Fig. 3 Graphical illustration of the correlation between Tm and the
number of incorporations of X (red), Y (blue) and Z (green; no entries) in
the DNA : RNA duplexes.
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CD spectroscopy
In order to investigate the overall structural changes imposed
by Y and Z, the unmodified and modified duplexes were evalu-
ated with circular dichroism (CD) spectroscopy. The CD
spectra were recorded in the 200–350 nm range using 1.5 μM
concentrations of each strand dissolved in PBS buﬀer. A static
temperature of 10 °C was used for duplexes containing Y, and
5 °C was used for duplexes containing Z, in order to ensure
that most of the oligonucleotides were in the hybridized form.
The CD spectra of duplexes containing Y and Z are shown in
Fig. 4, and the CD spectra of duplexes containing X can be
found in ref. 6 and 7a. The CD spectrum of the single-stranded
RNA (3′-rCACAAAACG) is also included in the DNA : RNA
figures, since this oligonucleotide was found to show large
Cotton eﬀects on its own. The CD bands arising from the
single-stranded DNA strands were found to be completely neg-
ligible, and are not included.
As expected, the unmodified DNA : DNA duplex adopts
bands that are typical of B-type helix such as CD maxima at
∼285 and ∼220 nm, CD minimum at ∼250 nm, and a clear
cross-over point at the absorption maxima ∼260 nm.20 Upon a
single incorporation of Y (Fig. 4A, entry 6), no significant
change in the CD curve was observed. However, upon introdu-
cing multiple Y residues (entries 7–9), a progressive transition
toward the A-type helix was observed, epitomized by a distinct
blue shift of the CD maximum at 285 nm and an intensifying
negative band at 210 nm, which are the spectral features of
A-type helices. In addition, new bands evolve at ∼310 and
∼235 nm, reflecting local geometry changes in the structures
that are neither typical of A- nor B-type helices, but possibly
arise from the stacking uracil–triazole moieties. While the
bands at ∼235 nm were also present upon multiple incorpor-
ations of X, it is much more intense for Y than Z, and the
Table 2 Hybridization data for the synthesized oligonucleotides against
mismatched RNA
# Sequences [*]=
Tm
a (ΔTm) [°C]
A U G C
1 5′-dGTG XXX XGC 51.5b 31.0b (−20.5) 42.0b (−9.5) 24.0b (−27.5)
3′-rCAC A[*]A ACG
2 5′-dGTG YYY YGC 52.0 30.1 (−21.9) 43.2 (−8.8) 34.0 (−18.0)
3′-rCAC A[*]A ACG
aMelting temperatures (Tm) are derived from the maxima of the first
derivatives of the absorbance (260 nm) vs. temperature curves. The
samples contained 1.5 μM of each oligonucleotide strands in PBS
buﬀer (2.5 mM Na2HPO4, 5.0 mM NaH2PO4, 100 mM NaCl, 0.1 mM
EDTA, pH 7). Values in brackets show changes in the Tm values com-
pared to the duplexes with [*] = A. b This value is taken from ref. 6.
Fig. 4 CD spectra (200–350 nm) of (A) DNA : DNA duplexes featuring Y at 10 °C (entries 6–9), (B) DNA : DNA duplexes featuring Z at 5 °C (entries
10–12), (C) DNA : RNA duplexes featuring Y at 10 °C (entries 6–9), and (D) DNA : RNA duplexes featuring Z at 5 °C (entries 10–12). Recorded in PBS
buﬀer (2.5 mM Na2HPO4, 5.0 mM NaH2PO4, 100 mM NaCl, 0.1 mM EDTA, pH 7) using 5 mm quartz cuvettes and a split width of 2 nm.
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band at ∼310 nm was completely absent in the case of X.
However, in general, the structural impacts by introducing X
and Y in DNA : DNA duplexes are rather similar, and both
induce a gradual shift towards an A-type duplex.6,7a
The CD curve of the DNA : DNA duplex containing a single
incorporation of Z (Fig. 4B, entry 10) was largely similar to the
unmodified duplex—like in the case of Y—suggesting that a
single Z residue does not profoundly aﬀect the secondary
structure. With 2× Z (entry 11), a small shift toward the more
compact A-type duplex was observed, however, with 3× Z (entry
12), the duplex structure appears essentially absent.
As shown in Fig. 4C and D, the unmodified DNA : RNA
duplex adopts a conformation somewhere between the stan-
dard A- and B-type geometries with a sharp CD maximum at
∼265 nm (A-type), a shoulder at ∼285 nm (B-type), a positive
band at ∼220 nm (B-type), and negative bands at ∼245 nm
(B-type) and ∼210 (A-type). Upon a single incorporation of Y
(Fig. 4C, entry 6) in the DNA : RNA duplex, no distinct change
in the CD profile was observed, analogous to DNA : DNA. But
with each additional incorporation of Y residues (entries 7–9),
a gradual shift toward an A-type duplex was observed, por-
trayed by the drop in the intensities of the archetypal B-type
bands at ∼285 and ∼220 nm, and an intensity gain at
∼265 nm. This shift towards an A-type duplex and the new
band at 240 nm was also observed in the CD spectra of
duplexes featuring X, although to a lesser degree.6,7 Like in the
case of DNA : DNA, a weak band appears in the low-energy
region (∼320 nm) of the duplexes containing 3× Y and 4× Y,
which was completely absent for the duplexes containing X.
For the DNA : RNA duplexes containing Z (Fig. 4D), all CD
spectra show that, in fact, no duplexes are formed upon
mixing the complementary strands, which is particularly
evident by the lack of any negative-to-positive Cotton eﬀects in
the 200–210 nm-region. The CD curves appear as duplicates of
the recorded spectrum of the single-stranded RNA, except that
they are slightly perturbed by the weak CD bands of the single-
stranded DNA.
Molecular modelling
To better understand the thermal and structural changes
induced by X, Y and Z in duplexes, the monomers were sub-
jected to molecular mechanical conformational analyses.
Within their base moiety, the monomers contain two
rotational axes, i.e. the bond between the triazole and the
nucleobase (φ), and the bond between the triazole and the
phenyl/uracil substituents (ψ). To facilitate speedy calculation,
the sugar portions were replaced by a methyl group. These
model structures were energy-minimized by DFT calculations
under vacuum using the B3LYP hybrid functional and the
6-31G** basis set, and then subjected to coordinate scans
using OPLS-2005 force field parameters21 (MacroModel V10.4,
release 2014-2) in GB/SA solvation.22 Scanning from 0–360° in
1° increments for both φ and ψ dihedral angles generated 3612
= 130 321 structures per search, which were individually mini-
mized, allowing all degrees of freedom to vary except φ and ψ.
The energy plots of the model compounds in their (φ,ψ)
spaces, and the global minimum structures in ball-and-stick
models, are shown in Fig. 5.
Fig. 5 Lowest-energy ball-and-stick models, and relative potential energy contour plots (in units of kJ mol−1) of the model compounds of X, Y and
Z in their (φ,ψ) spaces. The contour interval is set to 2 kJ mol−1 (is best viewed on screen). Calculations were carried out using OPLS-2005 para-
meters and using 1° increments from 0–360° for both φ and ψ.
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As shown in the (φ,ψ) contour maps, the conformational
spaces for the model compounds of X and Y are somewhat
similar and both contain a deep global minimum at (φ,ψ) =
(0°,180°). The φ = 0° minimum signifies a strong conformation-
al preference for a syn coplanar nucleobase–triazole torsion
stabilized by a weak 2.5 Å CH…O interaction between the nucleo-
base O4 and the triazole H atom. The ψ = 180° minimum in Y
corresponds to an anti coplanar orientation, seemingly stabil-
ized by another weak 2.4 Å interaction between the distal uracil
O4 atom and the triazole H atom. Therefore, both X and Y favor
having the three ring systems in the same plane. Notably, the
calculated barrier to conformational transition from the global
minimum to various local minima is higher for Y than X, which
is, at least in parts, due to this interaction.
In contrast to X and Y, the model compound of monomer Z
favors a syn but non-coplanar orientation of the nucleoside–
triazole bond. It has a pair of symmetry related global minima at
(φ,ψ) = (32°,34° ± 180°) and (φ,ψ) = (328°,146° ± 180°). Both the
two possible conformations with the three ring systems in the
same plane are disfavored by steric hindrance, indicating that
conjugation of π electrons is eﬀectively broken between the aro-
matic moieties. Interestingly, monomer Z has a pair of symmetry
related secondary minima (+2 kJ mol−1) at (φ,ψ) = (140°,154° ±
180°) and (φ,ψ) = (220°,206° ± 180°), which are entirely enclosed
within the +8 kJ mol−1 contour of the global minimum.
In order to visualize how the 5-substituents of X, Y and Z
influence the helical topology of the duplexes, and to establish
the degree of stacking of the aromatic moieties in the duplex,
the global minimum structures of the duplexes containing X,
Y and Z were obtained from 5 ns molecular dynamics (MD)
simulations using the all-atom AMBER* force field (Macro-
Model V10.4, release 2014-2) in GB/SA solvation. The unmodi-
fied duplexes and the duplexes featuring X and Y were
modeled at a constant 25 °C, whereas duplexes featuring Z
were modeled at 5 °C in order for the geometry minimizations
to successfully converge. The global minimum structures from
the MD simulations are shown in Fig. 6 and 7 for modeled
DNA : DNA and DNA : RNA structures, respectively.
As expected, the modeled DNA : DNA duplexes are B-type
helices with the 5-substituents of X, Y and Z situated in the
major groove. In line with the CD spectra, no significant per-
turbation of the helix structure occurs when introducing single
incorporations of X, Y or Z. As expected from the confor-
mational analysis, the Watson-Crick face of the additional
uracil moiety in Y is placed toward the core of the duplex.
However, while the aromatic rings of X and Y are aligned in
the plane of the nucleobases (perpendicular to the axis of the
duplex), the phenyl group of monomer Z points away from the
duplex core. This conformation of Z corresponds precisely to
the energetically favored syn periplanar torsion of the nucleo-
base–triazole bond. In the duplex with 2× Z, the 5-substituents
are not aligned in parallel planes and do not appear to engage
in any stacking interactions. In fact, one of the Z residues
adopts the less-favored anti periplanar spatial orientation in
Fig. 6 Global minimum structures obtained by 5 ns MD simulations of selected DNA : DNA duplexes from Table 1: monomer X (entries 2 + 5),
monomer Y (entries 6 + 9), and monomer Z (entries 10 + 11). The calculations were performed using the all-atom AMBER* force ﬁeld in GB/SA sol-
vation (van der Waals 8 Å and electrostatics 20 Å). The 5-substituents are shown with space-ﬁlling.
Organic & Biomolecular Chemistry Paper
This journal is © The Royal Society of Chemistry 2016 Org. Biomol. Chem., 2016, 14, 4436–4447 | 4441
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
1 
A
pr
il 
20
16
. D
ow
nl
oa
de
d 
on
 0
7/
02
/2
01
7 
08
:3
5:
41
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online
order to accommodate both modifications. This behavior
appears to induce a slight unwinding of the helix. In the
duplexes with 4× X or 4× Y, the 5-substituents appear to
strongly stack in the major groove, although they appear to
shift the helix toward the more compact A/B-type. This is par-
ticularly apparent in the duplex with 4× Y, where the bending
of the duplex appears to enable a few additional 1.8–2.0 Å
hydrogen bonding interactions between the additional uracil
and the nucleobases, while at the same time conserving all
Watson-Crick base pairs.
Essentially the same picture was observed for X, Y and Z in
DNA : RNA structures. Monomers X and Y are well-accommo-
dated in the major grooves of the duplexes, and consecutive
incorporations stack strongly and induce a slight compression
of the duplex. But while the Z residue almost retains the same
conformation as in the case of DNA : DNA, even a single in-
corporation appears to induce a slight unwinding of the helix.
Notably, the two adjacent incorporations of Z stack eﬃciently
on the outside of the duplex, however, in doing so, they induce
unwinding of the duplex.
Discussion
Although some excellent artificial DNA building blocks,23 such
as locked nucleic acids,24 have pushed the stability of nucleic
acid duplexes to a new level, the strategy of using simple 5-sub-
stituted pyrimidine nucleotides benefits from their easy tech-
nical preparation and their less perturbing consequences on
the sugar pucker and helix geometry, which is important for
many biological applications. With our previously-published
monomer X,6,7a we have devised a feasible technique to signifi-
cantly stabilize duplexes by enhancing the inherent stacking
interactions of the DNA : RNA duplexes, and recently we have
shown that 5-substituted phenylpyrazole dC analogs stack par-
ticularly strongly with X,17 allowing eﬃcient targeting of
homo-purine sequences.
In the present study, we have evaluated the consequences
of replacing the apolar phenyl substituent of X with the
very polar uracil substituent (monomer Y), and the conse-
quences of swapping the 1,4-disubstituted triazole in X with
a 1,5-disubstituted derivative (monomer Z). The thermal
and structural eﬀects imposed by these two new analogs of
X in the center of 9-mer DNA : DNA and DNA : RNA duplexes
were examined by UV and CD spectroscopy. Monomers Y
and Z were conveniently synthesized in a few synthetic
steps starting from 5-ethynyl-2′-deoxyuridine by employing
high-yielding Cu(I)- and Ru(II)-catalyzed alkyne–azide
cycloadditions, respectively, and their incorporation into
oligonucleotides as DMT-protected phosphoramidites 3 and
8 was very eﬃcient.
Compared to X, the oligonucleotide featuring a single polar
Y residue was found to have a slightly higher aﬃnity toward
complementary RNA and a significantly higher aﬃnity toward
Fig. 7 Global minimum structures obtained by 5 ns MD simulations of selected DNA : RNA duplexes from Table 1: monomer X (entries 2 + 5),
monomer Y (entries 6 + 9), and monomer Z (entries 10 + 11). The calculations were performed using the all-atom AMBER* force ﬁeld in GB/SA sol-
vation (van der Waals 8 Å and electrostatics 20 Å). The 5-substituents are shown with space-ﬁlling.
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complementary DNA, which appears to arise from the fact that
the uracil substituent on Y is much better solvated in the
duplex than the hydrophobic phenyl group on X. With mul-
tiple modifications, monomer Y appears to be equipotent to X
in terms of increasing the aﬃnity toward complementary RNA.
That is, for each triazole moiety stacking on top of another tri-
azole moiety, an increase in the Tm of the duplex of about
+7 °C was observed. In general, fine base-pairing fidelity was
observed with the oligonucleotide containing four Y residues,
although a central A to C mismatch discrimination was
smaller compared to the case of X. According to CD spec-
troscopy and molecular modelling, some diﬀerences in the
duplex structure were indicated. Notably, 4× Y residues induce
a slight bending of the duplex, possibly due to more eﬃcient
stacking interactions and hydrogen bonding interactions
across the major groove, and the CD spectrum supported this
deviation from the standard A/B-type duplex. Indeed, these
secondary interactions via the additional uracil moiety makes
monomer Y a so-called double-headed nucleotide.25,26 We
have previously decorated DNA duplexes with additional
nucleobases in the major groove26 for use as double-coding
DNA systems that could turn out to be important tools in
nucleic acid nanotechnology in the future. With monomer Y,
with its triazole linker between the nucleobases, we now have a
double-headed nucleotide with unprecedented thermostabiliz-
ing properties.
In the case of targeting DNA, oligonucleotides containing at
least three consecutive Y were found to display increased
aﬃnities toward complementary DNA relative to the unmodi-
fied oligonucleotide; and, in doing so, they significantly out-
perform X. This stacking aﬃnity inequivalence between X and
Y in DNA : DNA but not in DNA : RNA indicates that the higher
vertical rise of B-type helices houses the stacking of polar aro-
matic moieties better than apolar moieties. Nevertheless, it is
interesting to note that Kool and co-workers found that halo-
genated nucleoside isosteres stack more eﬃciently than the
canonical nucleobases when positioned as dangling resi-
dues,14c,27 and therefore they concluded that nonpolar ana-
logues stack more strongly, in general, than the more polar
natural bases.14c We now conclude that this correlation
appears to be reversed, when the modification is situated in
the major groove. Upon each incorporation of Y in DNA : DNA,
a gradual shift toward an A/B-type helix geometry was
observed, however, this geometry impact is similar to X and is
presumably negligible in longer sequences.
Surprisingly, oligonucleotides bearing monomer Z were
found to have extraordinarily low aﬃnities toward both comp-
lementary DNA and RNA compared to the unmodified oligo-
nucleotide. This result is most precisely explained in terms of
structural issues, since the helical geometries of the resulting
duplexes were severely aﬀected by the presence of Z according
to the molecular modeling. Either way, this is indicative of the
extraordinary destabilizing eﬀects of Z in duplexes. Remark-
ably, this complete depression in duplex formation arises
from just a delicate positional isomerism of the triazole ring
(1,4 vs. 1,5).
Conclusions
In this study, the eﬃciency of stacking interactions in the
major groove of our previously published 1-phenyltriazol-4-yl
scaﬀold (monomer X) have been altered by, respectively, repla-
cing the phenyl substituent with a polar uracil-5-yl substituent
(monomer Y), and replacing the 1,4-triazole with its 1,5-deriva-
tive (monomer Z). While consecutive incorporations of
monomer X thermally stabilizes DNA : RNA duplexes signifi-
cantly due to eﬃcient stacking, the corresponding 1-phenyl-
triazol-5-yl modification (monomer Z) does not engage in
stacking interactions and eﬀectively undermines duplex for-
mation. Thus, this study signifies that the precise spatial orien-
tation of the phenyltriazole moieties is absolutely crucial for
optimal duplex stability. Concerning the polarity of the 5-sub-
stituent, the single incorporation of a polar 1-uracil-5-yltriazol-
4-yl modification (monomer Y) was found to be energetically
much more favored than the apolar 5-substituent of monomer
X. Comparing the thermal eﬀects of multiple incorporations,
the stacking of Y residues appears, in general, marginally
better than the stacking of X residues in terms of increasing
the melting temperatures of the DNA : RNA duplexes, and Y is
clearly superior to X in terms of stabilizing homo-DNA
duplexes. As a result, monomer Y is a promising candidate in
RNA- and DNA-targeting oligonucleotides.
Experimental section
All reagents were used as supplied except CH2Cl2, which was
distilled prior to use. Microwave irradiated reactions were con-
ducted in sealed reaction vessels in a Biotage Initiator+ instru-
ment using external surface sensor probes. All reactions were
monitored by TLC using silica gel (60 F254) precoated plates.
Flash chromatography was performed using silica gel 60 (par-
ticle size 0.040–0.063 mm). For the purification of DMT-pro-
tected nucleosides, the silica gel was pretreated with 1%
pyridine in CH2Cl2 (v/v). HRMS-ESI was recorded on a quadru-
pole-time of flight instrument in positive ion mode with an
accuracy of ±5 ppm. 1H, 13C and 31P NMR spectra were
recorded at 400.12 MHz, 100.62 MHz and 161.97 MHz, respec-
tively. Chemical shifts are reported in ppm relative to tetra-
methylsilane (δH,C 0 ppm) or the deuterated solvents (DMSO
δc 39.5 ppm, CDCl3 δc 77.16 ppm). For
31P NMR spectra, 85%
H3PO4 was used as external standard. 2D spectra (HSQC, COSY
and HMBC) have been used in assigning 1H and 13C NMR
signals.
5-Azidouracil16
To a magnetically stirred solution of 5-aminouracil (2.25 g;
17.7 mmol) in H2O (150 mL) was added TsOH·H2O (30.3 g;
160 mmol) and NaNO2 (11.0 g; 160 mmol). The reaction
mixture was stirred at rt for 1 h, upon which NaN3 (1.84 g;
28.4 mmol) was slowly added. After the bubbles had settled
(∼15 min), the reaction mixture was cooled to 5 °C, and the
precipitate was filtered through a sintered glass funnel to
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obtain 5-azidouracil as a light beige solid (1.28 g; 8.4 mmol).
Yield: 47%. Rf 0.4 (50% MeOH in CH2Cl2). M.p. 98–99 °C
(decomp.) 1H NMR (400 MHz, DMSO-d6): δ 11.55 (br, 1H, NH),
10.97 (br, 1H, NH), 7.31 (s, 1H; H6). 13C NMR (101 MHz,
DMSO-d6): δ 160.7 (C4), 150.0 (C2), 130.0 (C6), 112.0 (C5).
HRMS-ESI+: calcd for [C4H3N5O2]2-Na
+ m/z 329.0466, found
m/z 329.0433.
5′-O-(4,4′-Dimethoxytrityl)-5-(1-uracil-5-yl-1H-1,2,3-triazol-
4-yl)-2′-deoxyuridine (2). To a magnetically stirred solution of
nucleoside 1 (300 mg; 0.54 mmol) and 5-azidouracil (165 mg;
1.08 mmol) in a mixture of H2O and t-BuOH (20 mL; 1 : 1),
sodium ascorbate (107 mg; 0.54 mmol) and CuSO4·5H2O
(40 mg; 162 μmol) were added, and the reaction mixture was
stirred at rt for 3 h. The reaction mixture was diluted with
EtOAc (100 mL) and washed with brine (50 mL). The mixture
was filtered through a short Celite pad, and the organic phase
was separated and concentrated under reduced pressure. The
residue was purified by flash chromatography (0–10% MeOH
in CH2Cl2) to obtain nucleoside 2 as a white solid (288 mg;
0.41 mmol). Yield: 75%. Rf 0.5 (10% MeOH in CH2Cl2).
1H NMR (400 MHz, DMSO-d6): δ 11.79 (br, 2H, NH), 11.55 (br,
1H, NH), 8.51 (s, 1H, triazole H5), 8.38 (s, 1H, H6), 8.06 (s, 1H,
H6 in external uracil), 7.39 (d, J = 7.4 Hz, 2H, DMT), 7.32–7.23
(m, 6H, DMT), 7.18 (t, J = 7.3 Hz, 1H, DMT), 6.88–6.82 (m, 4H,
DMT), 6.19 (t, J = 6.5 Hz, 1H, H1′), 5.36 (br, 1H, 3′-OH),
4.24–4.19 (m, 1H, H3′), 3.96 (q, J = 4.3 Hz, 1H, H4′), 3.71 (s,
3H, DMT), 3.70 (s, 3H, DMT), 3.34 (br, 1H, 3′-OH), 3.23 (d, J =
4.3 Hz, 2H, H5′, H5′′), 2.30–2.25 (m, 2H, H2′, H2′′). 13C NMR
(101 MHz, DMSO-d6): δ 161.0 (C4), 159.3 (C4 in external
uracil), 157.9 (DMT), 150.2 (C2), 149.4 (C2 in external uracil),
144.7 (DMT), 138.53 (triazole C4), 138.52 (C6 in external
uracil), 135.7 (C6), 135.4, 129.6, 127.7, 127.6, 126.5 (DMT),
123.6 (triazole C5), 113.1 (DMT), 112.3 (C5), 104.8 (C5 in exter-
nal uracil), 85.7 (C4′), 85.6 (DMT), 85.2 (C1′), 70.3 (C3′), 63.6
(C5′), 54.9 (DMT), 48.5 (C2′). HRMS-ESI+: calcd for
C36H33N7O9-Na
+ m/z 730.2232, found m/z 730.2218.
5′-O-(4,4′-Dimethoxytrityl)-5-(1-uracil-5-yl-1H-1,2,3-triazol-
4-yl)-3′-O-(P-(2-cyanoethoxy)-N,N-diisopropylaminophos-phinyl)-
2′-deoxyuridine (3). Nucleoside 2 (280 mg; 0.40 mmol) was co-
evaporated with anhydrous 1,2-DCE (10 mL), and dissolved in
anhydrous CH2Cl2 (3 mL), upon which diisopropylammonium
tetrazolide (135 mg; 0.79 mmol) and 2-cyanoethyl-N,N,N′,N′-
tetraisopropyl-phosphordiamidite (238 mg; 0.79 mmol) were
added to the magnetically stirred solution. The reaction
mixture was stirred at rt for 12 h, and concentrated under
reduced pressure. The residue was purified by flash chromato-
graphy (0–5% MeOH in CH2Cl2) to aﬀord a colorless oil, which
was dissolved in CH2Cl2 (1 mL) and poured onto cold hexanes
(100 mL). The resulting precipitate was collected by decanta-
tion to obtain nucleoside phosphoramidite 3 as a white solid
(254 mg, 0.28 mmol). Yield: 71%. Rf 0.5 (5% MeOH in
CH2Cl2).
31P NMR (162 MHz, CDCl3): δ 148.77, 148.54.
HRMS-ESI+: calcd for C45H50N9O10P-Na
+ m/z 930.3310, found
m/z 930.3342.
3′,5′-Di-O-acetyl-5-(1-phenyl-1H-1,2,3-triazol-5-yl)-2′-deoxyuri-
dine (5). To a stirred solution of nucleoside 4 (249 mg;
0.74 mmol) in anhydrous THF (4 mL), were added Cp*RuCl-
(PPh3)2 (59 mg; 81 μmol), phenylazide (∼0.5 M solution in
MTBE; 1.48 mL; ∼0.74 mmol). The reaction mixture was sub-
jected to microwave irradiation at 100 °C for 1 h. The mixture
was concentrated under reduced pressure and purified by
flash chromatography (0–5% MeOH in CH2Cl2) to obtain
nucleoside 5 as a light reddish solid (269 mg; 0.59 mmol).
Yield: 80%. Rf 0.4 (5% MeOH in CH2Cl2).
1H NMR (400 MHz,
DMSO-d6): δ 11.72 (br, 1H, NH), 7.96 (s, 1H, triazole H5), 7.87
(s, 1H, H6), 7.60–7.49 (m, 5H, phenyl H), 6.15 (t, J = 7.0, 1H,
H1′), 5.13–5.11 (m, 1H, H3′), 4.19–4.12 (m, 3H, H4′, H5′, H5′′),
2.51–2.49 (m, 1H, H2′), 2.38 (ddd, J = 14.4, 7.0, 2.8 Hz, 1H,
H2′′), 2.06 (s, 3H, acetyl O), 1.96 (s, 3H, acetyl O). 13C NMR
(101 MHz, DMSO-d6): δ 170.0 (acetyl CO), 169.9 (acetyl CO),
160.3 (C4), 149.6 (C2), 141.3 (triazole C5), 136.6 (triazole C4),
134.8 (C6), 129.4 (phenyl C3), 129.1 (phenyl C4), 128.7 (phenyl
C1), 124.1 (phenyl C2), 101.6 (C5), 84.9 (C1′), 81.3 (C4′), 73.6
(C3′), 63.4 (C5′), 35.9 (C2′), 20.7 (acetyl CH3), 20.4 (acetyl CH3).
HRMS-ESI+: calcd for C21H21N5O7-Na
+ m/z 478.1333, found m/z
478.1351.
5-(1-Phenyl-1H-1,2,3-triazol-5-yl)-2′-deoxyuridine (6). Nucleo-
side 5 (264 mg; 0.58 mmol) was dissolved in anhydrous MeOH
(4 mL) and methanolic ammonia (7 N, 4 mL; 28.4 mmol) was
added. The reaction mixture was magnetically stirred at rt for
48 h, and concentrated under reduced pressure. The residue
was purified by flash chromatography (0–15% MeOH in
CH2Cl2) to obtain nucleoside 6 as a white foam (183 mg;
0.49 mmol). Yield: 85%. Rf 0.2 (10% MeOH in CH2Cl2).
1H
NMR (400 MHz, DMSO-d6): δ 11.63 (br, 1H, NH), 8.07 (s, 1H,
triazole H5), 7.92 (s, 1H, H6), 7.58–7.48 (m, 5H, phenyl H),
6.12 (t, J = 6.5 Hz, 1H, H1′), 5.23 (d, J = 4.3 Hz, 1H, 3′-OH), 4.97
(t, J = 4.9 Hz, 1H, 5′-OH), 4.16–4.09 (m, 1H, H3′), 3.75 (q, J =
3.4 Hz, 1H, H4′), 3.51–3.41 (m, 2H, H5′, H5′′), 2.11 (ddd, J =
13.2, 6.5, 3.7 Hz, 1H, H2′), 1.99 (dt, J = 13.2, 6.5, 1H, H2′′). 13C
NMR (101 MHz, DMSO-d6): δ 160.4 (C4), 149.7 (C2), 141.5 (C6),
136.7 (triazole C4), 134.6 (triazole C5), 130.5 (phenyl C1), 129.4
(phenyl C3), 129.1 (phenyl C4), 124.3 (phenyl C2), 101.0 (C5),
87.5 (C4′), 84.6 (C1′), 69.9 (C3′), 60.8 (C5′), 40.1 (C2′).
HRMS-ESI+: calcd for C17H17N5O5-Na
+ m/z 394.1122, found m/z
394.1123.
5′-O-(4,4′-Dimethoxytrityl)-5-(1-phenyl-1H-1,2,3-triazol-5-yl)-
2′-deoxyuridine (7). Nucleoside 6 (109 mg; 0.29 mmol) was co-
evaporated with anhydrous pyridine (2 × 5 mL) and dissolved
in anhydrous pyridine (10 mL). DMTCl (129 mg; 0.38 mmol)
was added and the reaction mixture was magnetically stirred at
rt for 18 h. The mixture was concentrated under reduced
pressure and purified by flash chromatography (0–5% MeOH
in CH2Cl2) to obtain nucleoside 7 as a light yellow solid
(112.6 mg; 0.17 mmol). Yield: 57%. Rf 0.7 (10% MeOH in
CH2Cl2).
1H NMR (400 MHz, DMSO-d6): δ 11.71 (br, 1H, NH),
7.70 (s, 1H, triazole H5), 7.63 (s, 1H, H6), 7.44–7.40 (m, 3H,
phenyl), 7.36–7.30 (m, 4H, phenyl, DMT), 7.24–7.12 (m, 7H,
DMT), 6.83 (d, J = 7.5 Hz, 2H, DMT), 6.82 (d, J = 7.5 Hz, 4H,
DMT), 6.14 (t, J = 6.4 Hz, 1H, H1′), 5.30 (d, J = 4.7 Hz, 1H,
3′-OH), 4.02–3.97 (m, 1H, H3′), 3.87–3.84 (m, 1H, H4′), 3.69 (s,
6H, DMT), 3.10–3.02 (m, 2H, H5′, H5′′), 2.22–2.08 (m, 2H, H2′,
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H2′′). 13C NMR (101 MHz, DMSO-d6): δ 160.3 (C4), 158.00
(DMT), 157.95 (C2), 144.5 (DMT), 140.5 (C6), 136.6 (triazole
C4), 136.5 (triazole C5), 134.4, 129.9, 129.6, 129.4, 129.3, 129.0,
127.7, 127.5, 113.0 (phenyl, DMT), 101.3 (C5), 85.5 (C4′), 85.4
(C1′), 70.0 (C3′), 62.9 (C5′), 54.9 (DMT), 54.9 (DMT), 40.5 (C2′).
HRMS-ESI+: calcd for C38H35N5O7-Na
+ m/z 696.2429, found m/z
696.2433.
5′-O-(4,4′-Dimethoxytrityl)-5-(1-phenyl-1H-1,2,3-triazol-5-yl)-
3′-O-(P-(2-cyanoethoxy)-N,N-diisopropylaminophosphin-yl)-2′-
deoxyuridine (8). Nucleoside 7 (71 mg; 105 μmol) was co-evap-
orated with anhydrous 1,2-DCE (2 × 2 mL) and dissolved in
anhydrous 1,2-DCE (4 mL). Diisopropylammonium tetrazolide
(36 mg; 0.21 mmol) and 2-cyanoethyl-N,N,N′,N′-tetraisopropyl-
phosphor-diamidite (63 mg; 0.21 mmol) were added, and the
reaction mixture was magnetically stirred at rt for 18 h. The
mixture was concentrated under reduced pressure, and puri-
fied by flash chromatography (0–5% MeOH in CH2Cl2) to
aﬀord a colorless oil, which was dissolved in CH2Cl2 (1 mL)
and poured onto cold hexanes (100 mL). The resulting precipi-
tate was collected by filtration to obtain nucleoside phosphor-
amidite 8 as light brown foam (46 mg, 0.28 mmol). Yield:
50%. Rf 0.5 (5% MeOH in CH2Cl2).
31P NMR (162 MHz,
CDCl3): δ 149.05, 148.86. HRMS-ESI
+: calcd for
C47H52N7O8P-Na
+ m/z 930.3310, found m/z 930.3342.
Synthesis of oligonucleotides
Oligonucleotides were synthesized on a fully-automated DNA
synthesizer in ∼0.2 μmol scale loaded on 500 Å controlled-pore
glass (CPG) supports using the phosphoramidite approach
and following the manufacturer’s protocol. Double coupling
(2 × 5 min) cycles were used for commercial phosphoramidites
and prolonged coupling times (20 minutes) were used for the
modified phosphoramidites 3 and 8. The phosphoramidites
were activated using 1H-tetrazole, and incorporated into oligo-
nucleotides via manual couplings: 10 µmol of the modified
phosphoramidite was dissolved in anhydrous MeCN (2 mL)
and treated with 1H-tetrazole (3 mL, 0.45 M solution in
MeCN), and infused into the reaction compartment. The step-
wise coupling eﬃciencies were monitored by measuring the
absorbance of the trityl cation at 495 nm, which in all cases
were 98–100% for the commercial phosphoramidites, and
95–100% for the modified phosphoramidites. The final
5′-terminal DMT group in the oligonucleotides was retained
for purification purposes. The final crude oligonucleotides on
solid support were treated with NH3 (28% in H2O, 1 mL) at
55 °C for 16 h. The mixture was filtered and the filtrate was
evaporated to dryness at 45 °C by a steady N2 flow, and dis-
solved in an aqueous triethylammonium acetate buﬀer
(500 µL, 0.05 M, pH 7.4). Analytically pure oligonucleotides
were obtained by reversed-phase HPLC purification on a
Waters 600 system using Xterra MS C18 10 µm (7.8 × 50 mm)
columns and Xterra MS C18 10 µm (7.8 × 10 mm) precolumns.
Elution was performed with 100% eluent A over 2 min, fol-
lowed by a linear gradient down to 30% eluent A over 38 min,
and then washed with 100% eluent B over 10 min, and 100%
eluent A over 10 min. (Eluent A = triethylammonium acetate
(0.05 M, pH 7.4). Eluent B = 75% MeCN/H2O (3 : 1, v/v)). The
pure fractions were pooled and evaporated at 45 °C. The
5′-terminal DMT group was removed by treatment with acetic
acid (80% in H2O, 100 μL) for 30 min, upon which an aqueous
solution of NaOAc (15 µL, 3 M), an aqueous solution of
NaClO4 (15 µL, 5 M), and pure acetone (1 mL) were added. The
oligonucleotides precipitated overnight at −20 °C. The super-
natant was removed from the sedimented solid (centrifu-
gation, 12 000 rpm, 10 min at 2 °C), and the remaining pellet
was washed with cold acetone (3 × 1 mL) and dissolved in
500 µL pure water. Mass spectra of the oligonucleotides were
recorded on a MALDI-TOF MS instrument in ES+ mode. The
concentrations of the purified oligonucleotides were deter-
mined by the optical density at 260 nm, assuming that the
molar absorptivities of the oligonucleotides equal the sum of
each constituent nucleotide monomer. The extinction coeﬃ-
cients of the modified monomers in mL μmol−1 cm−1, ε260 (X)
= 7.8, ε260 (Y) = 5.8 and ε260 (Z) = 5.2, were determined from
the slopes of the absorbance of the fully deprotected nucleo-
sides at 25, 50, 75 and 100 μM concentrations (R2 > 0.9995).
Thermal denaturation experiments
The duplex samples consisted of 1.5 μM concentrations of
each oligonucleotide in phosphate buﬀered saline solution
(2.5 mM Na2HPO4, 5.0 mM NaH2PO4, 100 mM NaCl, 0.1 mM
EDTA, pH 7). The strands were annealed by heating the
sample to 80 °C followed by a slow cooling to 10 °C. The
increase in absorbance at 260 nm as a function of temperature
from 10 °C to 75 °C (1 °C min−1) was recorded on a UV/Vis
spectrometer using a Peltier Temperature Programmer. The
listed Tm values were determined as the first-derivative
maximum of the absorbance vs. temperature curves, and are
averages of at least duplicate determinations that agreed with
each other within 0.5 °C.
Circular dichroism spectroscopy
CD spectra were recorded on a Jasco J-715 spectropolarimeter
as a digital average of 5 scans from 200–350 nm using a split
width of 2.0 nm and a scan speed of 50 nm min−1. The
samples were prepared similarly to the samples used for the
melting temperature studies with 1.5 μM concentrations of
each strand. Quartz optical cells with an optical path length of
5.0 mm were used.
Molecular modelling
The global minimum structures were found from 5 ns mole-
cular dynamics simulations using the all-atom AMBER* force
field applying the GB/SA continuum solvation model22 with
extended cut-oﬀs for non-bonded interactions (van der Waals
8 Å and electrostatics 20 Å). Calculations were performed in
MacroModel V10.4 (within Maestro V9.8.017). The hybrid
duplexes were built in B-type helical geometries, and relaxed
with AMBER*. Initial Monte Carlo torsional samplings
(MCMM) were performed to generate 1000 structures, which
were individually minimized into local minima. The lowest
energy structure of each simulation was used for the sub-
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sequent MD simulations. The MD simulations were performed
at 300 K. The SHAKE all bonds to hydrogen setting was imposed
in order to increase the time step to 2.2 fs, and an equilibrium
time of 100 ps was used to stabilize the calculations. A multiple
minimization of the 500 sample structures was performed to
obtain a converged global minimum structure.
The torsional energy profiles were calculated on the geome-
try optimized structures (DFT/B3LYP/6-31G**) by a series of
fully relaxed coordinate scans of the dihedral angles φ and ψ.
The bonds defining the φ and ψ dihedral angles are shown in
Fig. 5. The computations were performed in MacroModel
V10.4 using the OPLS-2005 force field21 applying the GB/SA
solvation model. The torsional sampling was performed by 1°
increments of each of the dihedral angles (from 0° to 360°) to
obtain a total of 130 321 structures per search. The collection
of conformations was energy minimized by allowing all
degrees of freedom except φ and ψ which were frozen, the rela-
tive energies of which were plotted in the (φ,ψ) space using iso-
energy contours at 2 kJ mol−1 intervals.
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